Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia

Leuk Lymphoma. 2018 Apr;59(4):978-982. doi: 10.1080/10428194.2017.1361023. Epub 2017 Aug 10.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Flow Cytometry
  • Humans
  • Immunophenotyping / methods
  • Interleukin-3 Receptor alpha Subunit / analysis*
  • Interleukin-3 Receptor alpha Subunit / antagonists & inhibitors
  • Interleukin-3 Receptor alpha Subunit / immunology
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / immunology*
  • Molecular Targeted Therapy / methods
  • Patient Selection

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • IL3RA protein, human
  • Interleukin-3 Receptor alpha Subunit